Telix Pharmaceuticals Lim... (TLPPF)

PNK: TLPPF · Real-Time Price · USD

17.00

-0.00 (-0.01%)

At close: Apr 30, 2025, 1:33 PM

Telix Pharmaceuticals Balance Sheet Statement

Financials in AUD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q2 2024	Q1 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019	Q4 2018	Q2 2018	Q4 2017	Q2 2017
Period Ending	Dec 31, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Jun 30, 2023	Dec 31, 2022	Jun 30, 2022	Dec 31, 2021	Jun 30, 2021	Dec 31, 2020	Jun 30, 2020	Dec 31, 2019	Jun 30, 2019	Dec 31, 2018	Jun 30, 2018	Dec 31, 2017	Jun 30, 2017
Cash & Equivalents	710.35M	118.84M	80.02M	123.24M	131.73M	116.33M	122.61M	22.04M	49.62M	77.94M	24.38M	44.6M	10.15M	25.77M	26.37M	48.76M	5.9M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	15.67M	n/a	n/a
Long-Term Investments	6.09M	10.46M	8.94M	12.26M	-5.55M	-5.52M	n/a	n/a	183K	-4.22M	175K	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	74.58M	287.54M	2.33M	586K	450K	327K	-3.81M	-3.88M	-58.35M	183K	-4.22M	-4.14M	-3.08M	1.17M	35.29K	35.29K	n/a
Receivables	158.99M	97.27M	54.2M	64.78M	64.53M	39.35M	16.91M	19.42M	365K	12.4M	17.42M	12.07M	860.45K	8.44M	n/a	n/a	n/a
Inventory	38.14M	30.8M	12.52M	17.31M	12.6M	8.48M	6.53M	3.45M	889K	633K	446K	542K	983.24K	642.52K	n/a	n/a	n/a
Other Current Assets	n/a	8.35M	13.43M	7.1M	10.43M	6.57M	3.44M	1.43M	19.44M	1.79M	1.76M	938K	15.46M	534.66K	4.86M	786.05K	1.02M
Total Current Assets	918.56M	255.26M	160.16M	224.85M	219.29M	173.23M	149.5M	47.54M	70.31M	93.63M	44M	58.68M	27.45M	35.86M	46.9M	49.55M	6.93M
Property-Plant & Equipment	54.32M	38.26M	21.12M	30.49M	23.09M	18.84M	8.49M	6.33M	4.58M	4.82M	5.08M	1.9M	643.39K	226.17K	n/a	5.39K	n/a
Goodwill & Intangibles	416.13M	117.75M	73.42M	109.66M	64.38M	64.5M	61.77M	59.83M	57.94M	63.41M	48.83M	46.17M	40.48M	39.45M	1.58M	1.51M	n/a
Total Long-Term Assets	597.87M	490.7M	120.23M	173.45M	91.04M	87.36M	66.45M	62.27M	58.54M	70.81M	55.01M	43.93M	38.05M	40.85M	1.61M	1.55M	n/a
Total Assets	1.52B	745.96M	280.4M	398.3M	310.34M	260.59M	215.94M	109.81M	128.84M	164.44M	99.01M	102.61M	65.5M	76.71M	48.51M	51.09M	6.93M
Account Payables	68.7M	22.3M	13.84M	32.84M	33.97M	16.81M	10.54M	11.88M	4.46M	5.81M	2.13M	6.96M	2.42M	3.25M	3M	275.85K	458K
Deferred Revenue	11.25M	12.38M	5.51M	112.02M	8.36M	4.94M	10.24M	6.14M	3.04M	3.23M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	18.99M	3.78M	1.38M	964K	851K	n/a	555K	19K	552K	264K	2.41M	469K	1.13M	1.13M	364.69K	345.43K	n/a
Other Current Liabilities	109.67M	219.91M	56.25M	74.14M	107.8M	35.4M	35.46M	18.31M	17.27M	5.06M	5.65M	917K	3.31M	215.72K	411.56K	847.17K	n/a
Total Current Liabilities	330.91M	258.37M	98.05M	157.41M	142.63M	85.56M	46.55M	37.98M	22.29M	19.96M	10.18M	10.63M	6.86M	8.24M	3.78M	1.47M	458K
Long-Term Debt	551.82M	9.95M	6.56M	8.21M	12.25M	3.31M	2.01M	n/a	1.14M	95K	666K	292K	676.78K	596.29K	n/a	n/a	n/a
Other Long-Term Liabilities	44.67M	57.21M	45.21M	60.02M	52.69M	55.31M	42.75M	43.23M	28.43M	28.91M	26.48M	16.44M	14.76M	10.59M	n/a	n/a	n/a
Total Long-Term Liabilities	617.31M	83.61M	64.21M	91.98M	89.21M	92.88M	62.74M	68.19M	57.57M	64.49M	34.42M	21.25M	15.44M	15.56M	n/a	n/a	n/a
Total Liabilities	948.22M	341.98M	162.26M	249.39M	231.84M	178.44M	109.29M	106.17M	79.86M	84.44M	44.6M	31.88M	22.3M	23.8M	3.78M	1.47M	458K
Total Debt	581.45M	22.14M	12.44M	17.45M	13.1M	10.45M	2.57M	2.54M	1.7M	2.21M	3.08M	2.13M	1.8M	1.73M	364.69K	345.43K	n/a
Common Stock	n/a	587.41M	293.36M	446.27M	391.9M	370.97M	344.11M	170.84M	167.91M	167.06M	116.36M	115.94M	72.05M	72.05M	55.56M	55.56M	8.04M
Retained Earnings	-212.96M	-233.5M	-160.07M	-263.67M	-285.22M	-272.81M	-244.36M	-173.47M	-125.47M	-92.96M	-66.38M	-48.07M	-30.58M	-20.21M	-11.57M	-6.38M	-1.57M
Comprehensive Income	184.4M	50.07M	-15.15M	-33.69M	-30.62M	-18.15M	5.66M	4.79M	5.5M	4.92M	3.73M	2.21M	1.72M	1.06M	397.11K	109K	0.00
Shareholders Equity	568.21M	403.97M	118.14M	148.91M	76.06M	80.01M	105.41M	2.16M	47.93M	79.02M	53.72M	70.08M	43.2M	52.9M	44.39M	49.29M	6.47M
Total Investments	6.09M	10.46M	8.94M	12.26M	-5.55M	-5.52M	n/a	n/a	183K	-4.22M	175K	n/a	n/a	n/a	15.67M	n/a	n/a